We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+2.48%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.7B
AUM Growth
-$392M
(-1.7%)
Cap. Flow
-$683M
Cap. Flow
% of AUM
-3.01%
Top 10 Holdings %
Top 10 Hldgs %
13.52%
Holding
1,954
New
218
Increased
445
Reduced
978
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Weyerhaeuser
WY
|
+$41.7M |
| 3 |
Mondelez International
MDLZ
|
+$34M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$33.6M |
| 5 |
Lazard
LAZ
|
+$28.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$96.8M |
| 2 |
HCA Healthcare
HCA
|
+$70.3M |
| 3 |
HP
HPQ
|
+$51.1M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$49.2M |
| 5 |
T. Rowe Price
TROW
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.91% |
| 2 | Technology | 14.75% |
| 3 | Healthcare | 14.19% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Pacific Biosciences
PACB
$422M
| $755K | ﹤0.01% |
129,300
+78,657
| +155% | +$542K |
|
977
Central Garden & Pet Co Class A
CENTA
$2.41B
| $754K | ﹤0.01% |
88,750
+11,249
| +15% | +$90.3K |
|
978
Forrester Research
FORR
$172M
| $753K | ﹤0.01% |
20,500
+2,000
| +11% | +$75K |
|
979
Marriott International
MAR
$98.7B
| $753K | ﹤0.01% |
9,385
+1,185
| +14% | +$94.4K |
|
980
First Financial Corp
THFF
$922M
| $753K | ﹤0.01% |
21,000
-200
| -0.9% | -$6.84K |
|
981
American Coastal Insurance
ACIC
$498M
| $751K | ﹤0.01% |
33,400
-800
| -2% | -$19.1K |
|
|
EGL
982
DELISTED
Engility Holdings, Inc.
EGL
| $751K | ﹤0.01% |
25,000
+4,000
| +19% | +$160K |
|
|
AMRI
983
DELISTED
Albany Molecular Research Inc
AMRI
| $749K | ﹤0.01% |
42,600
-6,300
| -13% | -$107K |
|
984
REX American Resources
REX
$1.46B
| $747K | ﹤0.01% |
73,800
+600
| +0.8% | +$5.76K |
|
|
DNB
985
DELISTED
Dun & Bradstreet
DNB
| $747K | ﹤0.01% |
5,820
| – | – |
|
|
CAI
986
DELISTED
CAI International, Inc.
CAI
| $746K | ﹤0.01% |
30,400
+30,100
| +10,033% | +$696K |
|
|
MHFI
987
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $746K | ﹤0.01% |
+7,222
| New | +$709K |
|
|
SCMP
988
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $745K | ﹤0.01% |
47,900
-3,000
| -6% | -$46.5K |
|
|
ZEP
989
DELISTED
ZEP INC COM STK (DE)
ZEP
| $745K | ﹤0.01% |
43,800
-5,000
| -10% | -$81.6K |
|
|
KBAL
990
DELISTED
Kimball International
KBAL
| $744K | ﹤0.01% |
71,000
+7,900
| +13% | +$74.9K |
|
991
Spok Holdings
SPOK
$221M
| $743K | ﹤0.01% |
38,800
-3,600
| -8% | -$66.1K |
|
992
1st Source
SRCE
$2.07B
| $742K | ﹤0.01% |
25,410
-660
| -3% | -$19K |
|
|
BHBK
993
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $741K | ﹤0.01% |
56,100
+46,210
| +467% | +$604K |
|
|
OMN
994
DELISTED
OMNOVA Solutions Inc.
OMN
| $740K | ﹤0.01% |
86,800
-9,400
| -10% | -$73.5K |
|
995
VSE Corp
VSEC
$5.48B
| $736K | ﹤0.01% |
18,000
-5,800
| -24% | -$221K |
|
|
I
996
DELISTED
INTELSAT S. A.
I
| $735K | ﹤0.01% |
61,300
+16,100
| +36% | +$231K |
|
|
CBR
997
DELISTED
CIBER Inc.
CBR
| $732K | ﹤0.01% |
177,900
-35,400
| -17% | -$132K |
|
998
Vera Bradley
VRA
$105M
| $731K | ﹤0.01% |
45,100
+8,900
| +25% | +$164K |
|
999
Vince Holding Corp
VNCE
$76.2M
| $730K | ﹤0.01% |
3,940
+1,390
| +55% | +$311K |
|
|
AMTG
1000
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $730K | ﹤0.01% |
45,800
-1,200
| -3% | -$19K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q1 2015 Portfolio in Review
As of Q1 2015, STRS Ohio held 1,954 positions worth $22.7B, down 1.7% from $23.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
STRS Ohio withdrew a net $683M in Q1 2015, closing 152 positions and reducing 978 holdings. Its most notable exit was Allergan Inc, an estimated $96.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, STRS Ohio opened a new position in Lazard worth $30.5M.
- STRS Ohio's largest Q1 2015 buy was Lazard: 580,430 shares worth $30.5M.
- STRS Ohio added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- STRS Ohio's biggest Q1 2015 reduction was HCA Healthcare, cutting an estimated $70.3M.
- STRS Ohio fully exited Allergan Inc in Q1 2015, selling an estimated $96.8M.
- STRS Ohio's ten largest holdings make up 14% of its $22.7B portfolio in Q1 2015.
- STRS Ohio opened 218 new positions and closed 152 in Q1 2015.
- STRS Ohio's portfolio value fell 1.7% quarter-over-quarter to $22.7B.
Based on STRS Ohio's 13F filing for Q1 2015, filed 21 Apr 2015.